This compound is a carbamate derivative used as a pharmaceutical reference standard. Its structure features two carbamate groups and an ether linkage, and it is commonly employed in analytical testing and quality control for pharmaceutical manufacturing.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 25462-39-9
Iohexol EP Impurity E
pharmaceutical reference standard
2-Chloroadenosine 5'-Monophosphate Ditriethylamine Salt
pharmaceutical reference standard
(2S)-3-methyl-2-[2,2,3,3,4,4,5,5,5-nonadeuteriopentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
pharmaceutical reference standard
Valsartan impurity E
pharmaceutical reference standard
Sparsentan
dual endothelin and angiotensin receptor antagonist
3-Isoquinolinamine
active pharmaceutical ingredient
Lirafugratinib
orally bioavailable FGFR2 inhibitor
CLINDAMYCIN PALMITATE HYDROCHLORIDE
Active pharmaceutical ingredient
[2-(carbamoyloxymethyl)-2-methylpent-4-enyl] carbamate
JVAXHLUHJFLHDW-UHFFFAOYSA-N
CC(CC=C)(COC(=O)N)COC(=O)N